Table 3. Univariate analysis of factors associated with stroke recurrences.

	CAA-related ICH ( n = 60)		HTN-related ICH ( n = 103)
		HR (95% CI)	P value	HR (95% CI)	P value
Baseline clinical characteristics
Age	0.964 (0.893-1.041)	0.352	1.032 (0.985-1.081)	0.186
Male	2.073 (0.495-8.677)	0.318	1.226 (0.401-3.748)	0.721
Hypertension	0.577 (0.138-2.413)	0.451	/	/
Diabetes mellitus	1.861 (0.375-9.227)	0.447	0.632 (0.174-2.298)	0.486
Dyslipidemia	1.223 (0.142-7.537)	0.637	0.728 (0.331-1.601)	0.429
Previous stroke	0.494 (0.061-4.016)	0.510	1.700 (0.377-7.678)	0.490
Antiplatelet use	0.756 (0.222-4.078)	0.529	0.576 (0.067-5.387)	0.689
Statin use	1.275 (0.653-4.338)	0.264	0.835 (0.321-3.965)	0.189
Admission NIHSS	1.116 (0.960-1.297)	0.153	1.124 (0.986-1.280)	0.081
Admission GCS	0.749 (0.223-2.519)	0.641	0.728 (0.331-1.601)	0.429
Hematoma volume	1.033 (1.001-1.066)	0.045	1.012 (0.950-1.079)	0.710
Imaging markers of CVSD
Lacunes	2.120 (0.428-10.510)	0.357	6.132 (2.054-18.311)	0.001
CMBs	1.108 (0.892-1.376)	0.354	0.797 (0.258-2.455)	0.692
EPVS	0.771 (0.184-3.227)	0.722	1.957 (0.658-5.825)	0.228
WMH	1.376 (0.936-2.024)	0.105	1.251 (0.965-1.622)	0.091
cSS	1.979 (0.941-4.160)	0.072	2.176 (0.747-6.343)	0.154
The original SVD score	2.449 (1.076-5.575)	0.033	1.911 (1.193-3.061)	0.007
The modified SVD score	1.904 (1.051-3.448)	0.034	1.586 (1.047-2.403)	0.030
The refined SVD score	/	/	1.589 (1.007-2.507)	0.047
The CAA-SVD score	1.894 (1.216-2.950)	0.005	/	/
Total number of SVD markers	3.839 (1.505-9.794)	0.005	2.136 (1.218-3.745)	0.008

Abbreviation: HTN = Hypertension; CAA = Cerebral Amyloid Angiopathy; ICH = Intracerebral Hemorrhage; NIHSS = National Institutes of Health Stroke Scale; GCS = Glasgow Coma Scale; cSS = Cortical Superficial Siderosis; CMBs = Cerebral Microbleeds; WMHs = White Matter Hyperintensities; EPVSs = Enlarged Perivascular Spaces; CSO = Centrum Semiovale ; BG = Basal Ganglia; SVD = Small Vessel Disease.